Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
US Stock Insider Trading | Tectonic disclosed two insider trading transactions on March 5
On March 5, 2026, Tectonic (TECX) disclosed two company insider transactions. Executive McNamara Peter sold 1,650 shares on March 4, 2026.
[Recent Insider Trading]
[Company Profile]
Tectonic Therapeutic, Inc. is a company incorporated under the laws of Delaware. The company is a biotechnology company focused on discovering and developing therapeutic proteins and antibodies that modulate the activity of G protein-coupled receptors (“GPCRs”). Using its proprietary technology platform called GEODe (“GPCR Engineered for Optimal Discovery”), Tectonic focuses on developing biologics to overcome existing challenges in GPCR-targeted drug discovery, and on using the human body to alter the course of disease progression. Tectonic focuses on areas with significant unmet medical needs—areas that are typically characterized by poor or nonexistent treatment options—because new drugs in these areas have the potential to improve patients’ quality of life.